ED-LCS / Lung Cancer · Interventional Study

Increasing Equity in Lung Cancer Screening

ClinicalTrials.gov · September 10, 2026

Preliminary Why this matters to you Expert discussion

Early or partial results. Treat as a signal, not a conclusion.

AI Summary

This is a registry record for a planned pilot study of an Emergency Department Lung Cancer Screening behavioral intervention, currently recruiting. No efficacy, safety, or outcome data are reported in this registry entry. Results are not yet available to inform clinical practice.

What was studied

Interventional, Randomized, Parallel, Open label, Health Services Research purpose. Lung Cancer; age from 50 Years; to 80 Years; accepts healthy volunteers. Intervention: Intervention. Compared with: Usual Care — No Intervention. n = 144. 1 site: United States.

Key findings

Safety

Primary outcome timeframe is 6–12 months post-intervention; long-term efficacy and clinical endpoints (e.g., cancer detection, mortality) not addressed.

Who this may help

This pilot work will inform feasibility and acceptability of an ED-based lung cancer screening intervention. Clinicians should await results before considering implementation; current registry record contains no outcome evidence.

Plain-language summary

This is a registry record for a pilot interventional study with no posted results; enrollment is ongoing and primary outcome data are not yet reported.

Study design

As stated by the source record.

MethodsPrimary outcome measure: Rate of patients receive Lung Cancer Screening (assessed at 6-12 months)

DesignInterventional, Randomized, Parallel, Open label, Health Services Research purpose

PopulationLung Cancer; age from 50 Years; to 80 Years; accepts healthy volunteers

Sample size144

InterventionIntervention

ComparatorUsual Care — No Intervention

Setting1 site: United States

Reported figures

Quoted from the source exactly as published.

Estimated enrollment144

Primary outcome measureRate of patients receive Lung Cancer Screening, 6-12 months

Study typeInterventional

PhaseNA

Clinical bottom line

Caveats

No results are posted in this registry record; this is a study protocol only.
Enrollment is ongoing (RECRUITING status); final sample size and completion date not reported.
No control or comparator arm specified; study design details (randomization, blinding) not described in registry abstract.
Primary outcome timeframe is 6–12 months post-intervention; long-term efficacy and clinical endpoints (e.g., cancer detection, mortality) not addressed.

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Study design

moderate

Mixed-methods pilot with qualitative and quantitative components; design appropriate for phase.

Directness

moderate

Tests behavioral intervention in emergency department setting; primary outcome is screening rate uptake.

Consistency

insufficient

No results posted; consistency with prior work cannot be assessed from registry record.

Risk of bias

insufficient

Registry record does not describe randomization, blinding, or control group allocation.

Sample adequacy

limited

Estimated 144 participants; pilot design typically underpowered for definitive efficacy claims.

What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.

Source abstract

Registry record from ClinicalTrials.gov (NCT06360822). This is a study registration, not published results. Lead sponsor: Indiana University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 144 participants (ESTIMATED). Conditions: Lung Cancer. Interventions: BEHAVIORAL: ED-LCS. Primary outcome measures: Rate of patients receive Lung Cancer Screening , 6-12 months. Brief summary: The overall objective of this mixed methods study is to: 1) Refine the Emergency Department Lung Cancer Screening (ED-LCS) intervention using qualitative interviews among key stakeholders; 2) pilot test the ED-LCS intervention evaluating the intervention efficacy, acceptability, and feasibility; and 3) provide an in-depth description of stakeholders' experiences with the ED-LCS intervention for future refinement.

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.

NCT06360822Indiana UniversityED-LCSLung Cancer